[HTML][HTML] Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015 …
A Cassini, LD Högberg, D Plachouras… - The Lancet infectious …, 2019 - thelancet.com
Background Infections due to antibiotic-resistant bacteria are threatening modern health
care. However, estimating their incidence, complications, and attributable mortality is …
care. However, estimating their incidence, complications, and attributable mortality is …
Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster
A Antoniadou, F Kontopidou, G Poulakou… - Journal of …, 2007 - academic.oup.com
Objectives Infections due to multidrug-resistant (MDR) Gram-negative pathogens in the ICU
have prompted the use of colistin, an antibiotic forgotten for decades. The aim of this …
have prompted the use of colistin, an antibiotic forgotten for decades. The aim of this …
Colistin susceptibility testing by Etest and disk diffusion methods
The accuracy of disk susceptibility methods for colistin against 778 bacterial pathogens was
evaluated in comparison with Etest using interpretive criteria available from the Clinical and …
evaluated in comparison with Etest using interpretive criteria available from the Clinical and …
Health-care-associated infections in neonates, children, and adolescents: an analysis of paediatric data from the European Centre for Disease Prevention and Control …
W Zingg, S Hopkins, A Gayet-Ageron… - The Lancet Infectious …, 2017 - thelancet.com
Summary Background In 2011–12, the European Centre for Disease Prevention and Control
(ECDC) held the first Europe-wide point-prevalence survey of health-care-associated …
(ECDC) held the first Europe-wide point-prevalence survey of health-care-associated …
Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens
G Poulakou, FV Kontopidou, E Paramythiotou… - Journal of Infection, 2009 - Elsevier
OBJECTIVE: This observational retrospective study aims to present early experience with
tigecycline (TIG) in the treatment of infections due to multi-drug resistant (MDR) …
tigecycline (TIG) in the treatment of infections due to multi-drug resistant (MDR) …
B‐chronic lymphocytic leukemia: practical aspects
GA Pangalis, TP Vassilakopoulos… - Hematological …, 2002 - Wiley Online Library
B‐CLL is the most common adult leukemia in the Western world. It is a neoplasia of mature
looking B‐monoclonal lymphocytes co‐expressing the CD5 antigen (involving the blood, the …
looking B‐monoclonal lymphocytes co‐expressing the CD5 antigen (involving the blood, the …
In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals
M Souli, FV Kontopidou, E Koratzanis… - Antimicrobial agents …, 2006 - Am Soc Microbiol
The in vitro activities of tigecycline and selected antimicrobials were evaluated against a
variety of multiple-drug-resistant clinical isolates, including extended-spectrum β-lactamase …
variety of multiple-drug-resistant clinical isolates, including extended-spectrum β-lactamase …
Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-β-lactamase in a Greek university hospital
M Souli, FV Kontopidou… - Clinical infectious …, 2008 - academic.oup.com
Background. The dissemination of acquired metallo-β-lactamases (MBLs) in members of the
family Enterobacteriaceae is regarded as an emerging clinical threat. The clinical …
family Enterobacteriaceae is regarded as an emerging clinical threat. The clinical …
Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group
NJ Tsagarakis, NA Kentrou, KA Papadimitriou… - Leukemia research, 2010 - Elsevier
We present a cohort of 22 patients with type 2 dendritic cell (DC2) acute leukemia (or blastic
plasmacytoid dendritic cell neoplasm-BPDCN, as it has been recently named), diagnosed in …
plasmacytoid dendritic cell neoplasm-BPDCN, as it has been recently named), diagnosed in …
Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care …
EI Kritsotakis, F Kontopidou, E Astrinaki… - Infection and drug …, 2017 - Taylor & Francis
Background Assessing the overall burden of healthcare-associated infections (HAIs) is
challenging, but imperative in evaluating the cost-effectiveness of infection control programs …
challenging, but imperative in evaluating the cost-effectiveness of infection control programs …